We studied the effects of fibrinogen degradation product (FDP) fragment D on endothelial monolayer integrity and the mechanisms of fragment D-induced endothelial cell detachment from the substratum. Incubation of bovine pulmonary artery endothelial cells (BPAEC) with fragment D caused concentration-and time-dependent cell detachment from the substratum. The optimal response occurred at fragment D concentrations of 2 $M and required an incubation time of 24 h.
Introduction
Fibrin(ogen) degradation products (FDPs)' generated during fibrinolysis have been implicated in tissue inflammation asso-1. Abbreviations used in this paper: Ab, antibody; ARDS, adult respiratory distress syndrome; BPAEC, bovine pulmonary artery endothelial cells; dansyl GGACK, dansyl Glu-Gly-Arg chloromethyl ketone; DMEM, Dulbecco's modified essential medium; FDP, fibrinogen degradation product; PA, plasminogen activator; PAI, plasminogen activator inhibitor; EPA, tissue-type plasminogen activator; uPA, urokinase-type plasminogen activator. ciated with the adult respiratory distress syndrome (ARDS), disseminated intravascular coagulation, and septic shock (1) (2) (3) (4) . Studies indicate that plasma concentrations of FDP fragment D are markedly elevated in these disorders (1, 4) . Saldeen (5) and Malik (3) have suggested that activation of fibrinolysis, and resulting generation of FDPs including fragment D, contributes to lung vascular injury. Infusion of fragment D into rabbits induced progressive thrombocytopenia, pulmonary dysfunction, and increased pulmonary vascular permeability, changes that were characteristic of ARDS (5, 6) .
Studies also indicate that fragment D has important effects on the endothelial cell barrier. Dang et al. (8) reported that fragment D detached bovine aorta endothelial monolayers from the substratum. Our previous studies indicated that fragment D increased bovine pulmonary artery endothelial monolayer permeability to '25I-albumin (9) . However, the basis of fragment D-induced endothelial injury is not known. In recent years, studies have demonstrated that plasminogen activators (PAs), plasminogen activator inhibitors (PAIs), and plasmin systems play a critical role in remodeling of the extracellular matrix and regulating cell-cell and cell-substratum adhesion (10) (11) (12) (13) . Endothelial cells can synthesize and secrete tissuetype plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) (14) (15) (16) . uPA is associated with cellsubstratum contact points ( 13, 16) and may be important in mediating cell detachment. Because FDPs are known to interact with PAs ( 17, 18) and fragment D causes endothelial cytoskeletal F-actin reorientation (9) and cell detachment (8), we hypothesized that fragment D-induced release of PAs by endothelial cells may be a critical event in mediating proteolysis of subendothelial proteins and thus may result in endothelial cell detachment. In the present study, we examined the effects of FDP fragment D on endothelial-derived PAs and their potential role in injuring the endothelial cell barrier. 
Fibrinogen purification
Human fibrinogen was purified from fresh plasma (obtained from Albany Red Cross, Albany, NY) by a modified glycine precipitation procedure ( 19) . Residual plasminogen and fibronectin were removed by lysine-Sepharose and gelatin-Sepharose affinity columns (Pharmacia Inc., Piscataway, NJ), respectively. Purified fibrinogen was > 96% clottable and showed intact a (65 kD), # (50 kD), and y (45 kD) chains when analyzed on SDS-PAGE. Overloading of fibrinogen on reduced SDS-PAGE did not reveal any detectable bands of 220 and 90 kD corresponding to fibronectin and Glu-plasminogen, respectively.
Preparation offragment D and E
Purified fibrinogen was digested with human plasmin (fibrinogen/ plasmin = 300:1 molar ratio) with 5 mM Ca2+ or 5 mM EGTA for 5 h at 370C. The time course of plasmin digestion was monitored by SDS-PAGE analysis. Plasmin digestion was terminated by adding excess Val-Phe-Lys-chloromethylketone.
Fragment D was isolated by QAE-Sephadex anion-exchange chromatography with modifications (20) . The plasmin digest of fibrinogen was applied to a 2.5 x 23 cm QAE-Sephadex column (Pharmacia Inc.) equilibrated in 0.1 M ethylene diamine acetate (EDA) buffer, pH 8.0. Fragment D was eluted from the column in two peaks. One portion of the fragment D (peak 1) was eluted with the equilibration buffer and the remainder (peak 2) was eluted by EDA buffer, pH 6.5. Fragment E (peak 3) was eluted with 0.2 M sodium acetate buffer, pH 4.4. The pH of each pool was adjusted to 7.4 and dialyzed against 10 mM Tris, 0.15 M NaCl, pH 7.4. Fragments D and E were further purified by gel filtration on Sephadex G-200 and Sephacryl S-200 columns (Pharmacia Inc.), respectively. The purity of various preparations was determined by SDS-PAGE and scanning densitometry. Protein concentration of fragments D and E were measured by absorbance at 280 nm in 0.1 N NaOH using extinction coefficients of E " = 20.8 and 10. 1, respectively (21) . After extensive dialysis against PBS (pH 7.4), the purified fragments were passed through a 0.22-,um hydrophilic nylon sterile filter (Lida Manufacturing Corp., Kenosha, WI) and a Detoxigel affinity Pak (Pierce Chemical Co., Rockford, IL) to remove possible endotoxin contamination. Preparations were stored at -70°C until the experiments.
Fragment D prepared with either 5 mM Ca2" or 5 mM EGTA showed single bands on SDS-PAGE with relative molecular masses (Mr) of 94 (D94) and 80 kD (Dgo), respectively. Fragment E migrated as a single band with a relative molecular mass of 50 kD. Both purified fragments D and E were further characterized by Western blotting and immunodiffusion assays. The purified fragments D and E reacted only with their corresponding Abs without detectable cross-contamination. Both preparations were free of contamination from plasminogen, plasmin, or PAs using assay of PA activity, plasmin activity, and '25I-fibrinogen degradation.
Plasminogen and plasmin preparations
Human native Glu-plasminogen and Lys-plasminogen were isolated from plasma and Cohn fraction III pastes (gift from Dr. H. S. Kingdon, Highland Laboratories, Glendale, CA) by lysine-Sepharose affinity chromatography as described (22) . Plasmin was prepared by activation of Lys-plasminogen with urokinase and characterized by p-nitrophenyl-p'-guanidinobenzoate titration and SDS-PAGE analysis as reported (22) .
Vitronectin purification Human vitronectin was purified from fresh plasma by heparin-Sepharose 4B affinity chromatography in the presence of urea as described by Yatohgo et al. (23) . SDS-PAGE analysis of the purified vitronectin revealed two bands with the molecular masses of 75 and 65 kD as reported ( 19) .
IgG purification
IgGs were purified from antisera (anti-bovine uPA, anti-fragment D, and anti-fragment E) or nonimmune rabbit serum using protein A-Sepharose affinity chromatography according to the manufacturer's instruction (Pharmacia Inc. Louis, MO) and 0.5% BSA (Sigma Chemical Co.), pH 7.4, without phenol red. Previous studies showed that these cells remained a confluent monolayer after 72 h in serum-free culture medium. Conditioned medium was collected at different time points after the interventions. The cells were washed (2X) with HBSS and lysed in 400 ,l of 0.5% Triton X-I00 for assaying PAs and plasmin or trypsinized for cell counts. The Triton-insoluble extracellular matrix was washed (2x) with HBSS for plasmin assay or scraped into SDS sample buffer for gel analysis.
Assay ofendothelial cell detachment
Endothelial cells were challenged with fragment D, fragment E, or control DMEM for different periods. Cell morphology was examined by phase contrast microscopy. The detached cells were removed at different time points by washing (3x) with HBSS. The remaining attached cells were detached from the underlying substratum by brief trypsin exposure and were counted using a hemocytometer. The viability of both attached and detached endothelial cells was determined by trypan blue dye exclusion. For analysis, the percent of detached cells was calculated from remaining attached cells by number of control cellsnumber of treated cells/number of control cells x 100.
Measurement ofPAs
Measurement ofantigens. A modified sandwich ELISA (24) was used to measure uPA in conditioned media and cell lysates. Wells of96-well microtiter plates were coated with a rabbit anti-bovine uPA polyclonal antibody as the capturing antibody. A goat anti-human uPA polyclonal antibody (which cross-reacted with bovine uPA) was used as the primary antibody. When compared with human urokinase standard, uPA concentrations of the assayed samples were in the range of 10 to 200 ng/ml. The absorbance values at 410 nm (A410) of control and fragment D-treated groups were compared to reflect uPA antigen levels. tPA antigen in the conditioned media was measured by ELISA using goat anti-porcine heart tPA polyclonal antibody, which crossreacted with bovine tPA.
Chromogenic analysis oftotal PA activity. Total PA activity (which comprised both uPA and tPA) was measured using the plasminogen activation assay ofColeman and Green (25) . Briefly, 10 Ml ofsample or uPA standard was incubated with 50 Ml of 0.12 mg/ml Lys-plasminogen in 0.12 M glycine buffer containing 0.05% BSA (Sigma Chemical Co.), pH 8.5 at 37°C for 45 min. The reaction mixture was then incubated with 1.74 mg/ml DTNB in PBS buffer containinng 0.2 M P04, tion was terminated by adding soybean trypsin inhibitor (1 mg/ml; 100 gld/tube) and the absorbance of the samples at 412 nm was read against blank H20 and corrected by plasminogen blank. The average of the duplicated absorbance values was used to calculate equivalent CTA Committee for Thrombolytic Activity (CTA) units/ml (U/ml) against a regression line of human uPA standards. For assaying fragment D-containing conditioned media, the calibration curve of the standard was made using same concentrations of fragment D in the assay mixture.
Zymographic analysis ofPA activity. The PAs in conditioned media and cell lysates were analyzed by casein/plasminogen SDS-PAGE zymography with modifications (26, 27) . The assay was performed on a mini-dual slab gel apparatus (Bio-Rad Laboratories). Lys-plasminogen (final concentration of 0.03 mg/ml) and casein (final concentration of 1 mg/ml) were copolymerized in a gradient SDS polyacrylamide gel. Samples of conditioned media and cell lysate were unboiled and nonreduced. After electrophoresis at 200 V for 45 to 60 min at 4VC, the gels were soaked in 2.5% Triton X-100 in H20 at room temperature for 60 min and incubated with 0.1 M glycine buffer (pH 8.3) at 370C for 3 to 5 h (longer incubation time was used for detecting tPA).
The gels were stained with Coomassie blue followed by destaining. Plasminogen-independent caseinolytic activity was determined by analyzing the same samples on gels containing casein but without plasminogen. The uPA or tPA activities were characterized by their respective molecular weights and using plasminogen/casein gels copolymerized with antibodies against tPA or uPA (27, 28).
Measurement ofplasmin activity
Conditioned media and Triton-cell lysates were incubated with plasmin substrate Val-Leu-Lys-pNA (S-225 1, final concentration of 0.35 mM) in a 96-well microtiter plate (final volume of200 Ml/well) for 60 min at room temperature. The Triton X-100-insoluble matrix was incubated with S-2251 for 60 min and the reaction mixture was transferred into a 96-well plate for reading absorbance. Plasmin activity was measured by reading the absorbance at 410 nm and was calculated against a plasmin standard regression line. , Subendothelial 125I-fibrinogen and -vitronectin degradation Fibrinogen was iodinated using a modified chloramine-T method (29) and vitronectin was iodinated using an iodogen reaction kit according to manufacturer's instruction (Pierce Chemical Co.). Free 125I was removed by gel filtration on a Sephadex G-25 column (Pharmacia Inc.) and dialysis. The 1251-fibrinogen-or 12'I-vitronectin-coated plates were prepared as described (30) . The 24-well culture dishes were coated with 0.1 ml of 1251-fibrinogen or 125I-vitronectin (200,000 cpm/well) in the presence of 100 uig/ml corresponding unlabeled proteins. After drying at 40°C in an oven, the coated plates were blocked with 0.4 ml of 1% BSA in PBS at room temperature for 1 h followed by washing (2x) with 1 ml of PBS. The plates were then sterilized by ultraviolet light overnight, and cells were seeded with 2X density. The cells reached confluency within 48 h after seeding.
Confluent BPAEC monolayers grown on the '251I-fibrinogen-or '251-vitronectin-coated surface were washed 3x with DMEM and challenged with control PBS or fragment D with or without the following agents: plasminogen, aprotinin, dansyl-GGACK, anti-uPA antibody, or nonimmune control IgG. Medium (20 ,l) (Fig. 1 a) . Treatment with fragment D (2 MM) for 8 h caused no significant morphological changes or cell detachment (Fig. 1 b) . Some cells were retracted at 12 h after fragment D challenge (Fig. 1 c) . However, incubation with 2
MuM fragment D for 24 h detached 50.8±4.0% (n = 9) (P < 0.01 ) of the cells from the substratum (Fig. 1 dand Table I (Fig. 1 e) . BPAEC treated with 4 ,MM of fragment E for 24 h caused less cell detachment compared with the fragment D-exposed cells (Fig. I f) .
Endothelial cell detachment produced by fragment D was independent of the COOH-terminal sequence of the y-chain on fragment D because fragment D80 (which lacks the y-carboxyl sequence of fragment D94 [ 31 ] ) produced a similar effect as fragment D94 (Table II) .
The presence of 20% serum in the incubating medium potentiated cell detachment mediated by fragment D (Table II) . This effect was also seen with 10 or 5% of serum. Serum passed through a lysine-Sepharose column to remove plasminogen or heated at 56°C for 30 (Table III) . Fragment E at 4 MM induced a small (statistically insignificant) increase in uPA antigen in the medium, which was significantly less than with fragment D (P < 0.05) ( Table III) .
Incubation of BPAEC with 2 MuM fragment D produced a time-dependent increase in uPA antigen in the conditioned medium; i.e., fragment D-treated endothelial cells increased the uPA antigen levels to 150.1±13.6 (n = 14) (P < 0.01 ) and 148.1±11.4% (n = 18) of the corresponding control values (P < 0.01) at 2 and 4 h, respectively (Fig. 2) . At 8 to 12 h, the medium uPA antigen concentrations were similar to the control values (P > 0.05) (Fig. 2) . Fragment D did not cause significant changes in uPA antigen concentrations in the Triton X-100-soluble cell fraction.
Fragment D-challenged BPAEC monolayers also increased the tPA antigen concentration in the conditioned medium compared with controls (Fig. 3); i.e., challenge with 2 MM fragment D for 2, 4, and 8 h increased tPA antigen to 182.2±18.0 (n = 20) (P < 0.01), 164.2±9.1 (n = 26) (P < 0.01), and 137.8±17.2% (n = 16) (P < 0.05) ofthe corresponding control values, respectively. At 12 h, the tPA antigen levels were similar to the control value (P > 0.05) (Fig. 3) .
PA activities. SDS-PAGE zymography indicated that untreated BPAEC monolayers constitutively released PAs into the incubating medium (Fig. 4 a) . More than 90% of the total PA activity in control BPAEC conditioned medium after 24 h incubation was inhibited by anti-bovine uPA IgG when analyzed by the chromagenic PA activity assay. Zymography analysis also indicated that most of the PA activity in control BPAEC conditioned medium was uPA (Mr 48 kD) (Fig. 4 Fragment D-mediated Endothelial Cell Detachment 2511 a), which was eliminated when anti-uPA Ab was copolymerized in the gel. Anti-uPA Ab also inhibited the caseinolytic activity of a 30-kD protein (Fig. 4 a) , which is a proteolytic product of uPA generated by plasmin cleavage (10) (11) (12) 14) . Fragment D increased the 48-kD uPA activity in the medium at 4 h, whereas the uPA activities at 8 and 24 h were similar to or lower than the constitutive release from control cells (Fig. 4  a) . The increase in uPA induced by fragment E at 4 h was less than that observed with fragment D. Zymographic analysis indicated that fragment D enhanced a band (Mr = 70,000) in the conditioned medium at 8 h (Fig. 4  a) . The 70-kD protein was identified to be tPA because it was inhibited by copolymerizing with an anti-tPA antibody in casein-plasminogen gel. The increase in tPA activity induced by fragment D was invariably less than the increase in uPA activity (Fig. 4 a) .
The fragment D-induced increase in PA activity assessed by the activity assay was evident after 30 min of incubation (n = 4) (P < 0.05) (Fig. 4 b and Table IV ). The response peaked within 2 h (201.6±14.9%) (n = 18) (P < 0.01 ) compared with the control value (Fig. 4 b) . The PA activity in the conditioned medium of fragment D-treated BPAEC gradually returned to the time-matched control levels after 6 h ( Fig. 4 a and Table  IV) . After 12 h, the PA activity in the media was less than the control value. The results of the PA activity assay were consistent with that of zymographic analysis (Fig. 4 a vs. b) . The effect of fragment D in increasing PA activity in the medium was also concentration dependent (Fig. 5, a and b) .
Effect offragment D on endothelial cell-associated plasmin activity Incubation ofendothelial monolayers with 2 ,uM offragment D increased the cell-associated plasmin activity at 2 h (Fig. 6 ). The plasmin activity remained elevated at 12 h (n = 4; P < 0.01; Fig. 6 ). The plasmin activity was not detectable in the conditioned medium or Triton-insoluble matrix fractions.
Fragment E (4 AM) also increased the cell-associated plasmin activity from the control value of0.295±0.014 to 0.363±0.018 nM/liter (P < 0.05) after 12 h of incubation; however, this effect was less than that caused by 2 MM of fragment D (P < 0.05).
Effects offragment D on degradation ofsubendothelial (Table V) . At 2, 4, and 8 h, the fragment D-induced release of '25I-fibrinogen fragments increased from control values of 550±85, 888±89, and 1154±77 to 760±87 (P < 0.05), 1094±80 (P < 0.05), and 1482±49 cpm/well (P < 0.05), respectively. Fragment D challenge also increased the release in '251-vitronectin fragments into the medium, which peaked at 4 h of fragment D challenge (P < 0.05; Table V ). These results indicate that fragment D-induced plasmin generation was capable of degrading subendothelial proteins. Addition of Glu-plasminogen (0.1 MM) augmented the release of '251-fibrinogen fragments into the medium by 10-fold.
This response was inhibited by pretreatment of BPAEC with anti-bovine uPA antibody (0.7 mg/ml), uPA inhibitor (dansyl-GGACK) ( 10-7 M), or the plasmin inhibitor (aprotinin) (200 U/ ml) (Fig. 7) . Pretreatment of nonimmune rabbit IgG (0.7 mg/ml) showed no effect (Fig. 7) . Similar results were obtained using BPAEC seeded on 1251I-vitronectin- aprotinin (n = 5) (P < 0.01), or 0.7 mg/ml of anti-bovine uPA antibody (n = 3) (P < 0.01) for 30 min before the fragment D challenge (Fig. 8) . In contrast, the nonimmune IgG showed no protective effect (Fig. 8) . These fragment D-induced endothelial release of PAs and the subsequent generation of cell-associated plasmin are critical events in endothelial cell detachment.
Discussion
Endothelial cells produce uPA and tPA ( 10-12, 14-16). Several studies have shown that uPA is associated with cell-substratum adhesion sites (10) (11) (12) 16 subendothelial sites may mediate the loss ofendothelial barrier function subsequent to proteolysis of subendothelial proteins.
Previous studies have suggested a critical role for high molecular weight FDPs in the inflammatory response ( 1-3). One major high molecular weight FDP, fragment D, is markedly elevated in the plasma ofARDS patients and has been linked to the development of lung vascular injury (4). Infusion of fragment D in rabbits caused lung injury associated with increased lung vascular permeability (6, 7) . In vitro studies indicate that fragment D increases transendothelial macromolecular transport, alters cytoskeletal F-actin, and disrupts the endothelial cell monolayer (8, 9) . In the present study, we observed that fragment D challenge for 24 h caused -50% detachment of BPAEC from the substratum, a process independent of the ,y-carboxyl sequence of fragment D. The finding that y-carboxyl peptide is not required for endothelial cell detachment is supported by previous studies (8, 9). Fragment D-induced endothelial cell detachment was reversible and was augmented by serum-containing medium. We speculate that serum contains factor(s) that interact with fragment D and thus are capable of potentiating the effect of fragment D. The nature of the serum cofactor(s) is not clear, but the present results ruled out plasminogen and complement constituents of serum.
Because fragment D is known to modulate PA-mediated plasminogen activation ( 17, 18, 33) , we examined the possibility that fragment D-induced endothelial cell detachment is mediated by release ofendothelial-derived PAs and subsequent activation ofcell-bound plasminogen. We tested the hypothesis that "upregulation" of endothelial cell-mediated fibrinolytic activity by fragment D degrades the extracellular matrix and progressively detaches cells from the substratum.
The results indicated that purified fragment D caused the release of uPA into the BPAEC-conditioned medium within 2 to 4 h of treatment, whereas fibrinogen showed no effect. Fragment D mainly increased 48-kD uPA and subsequently increased a 30-kD uPA. The latter is a degradation product ofthe 48-kD uPA, generated by limited plasmin proteolysis of the NH2-terminal cell-binding domain of uPA (10) (11) (12) . BPAEC produced relatively low levels of tPA after fragment D challenge, which was also released into the medium in the similar time frame. The increase in PA activity was associated with elevated uPA and tPA antigen concentrations in the medium. In contrast to fragment D, BPAEC challenged with fragment E resulted in smaller increases in uPA antigen in the conditioned medium. The effects of fragment E on endothelial release of uPA and plasmin generation were invariably less than those of fragment D, consistent with our previous observation that fragment D was more potent in increasing endothelial permeability than fragment E (9) .
Fragment D increased the plasmin activity in BPAEC lysates, but not in the BPAEC-conditioned medium, suggesting that the generated plasmin remained cell bound. In contrast to the relatively transient increases in uPA and tPA activities, the increase in cell-associated plasmin activity was sustained for the duration of the study. This may be the result of absence of plasmin inhibitors in the serum-free medium or binding of plasmin to cell membrane may protect the plasmin from inactivation (34) . We used the 25I-fibrinogen and '25I-vitronectin degradation assay (30) to determine whether the cell-bound plasmin altered the underlying extracellular matrix. Fragment D challenge of BPAEC monolayers increased the release of '25I-fibrinogen and '25I-vitronectin fragments into the conditioned medium. The time course ofdegradation ofthe radiolabeled proteins paralleled the increase in the cell-associated plasmin activity. Because uPA secreted into the basolateral compartment of bovine endothelial cells is associated with focal contact points ( 16) , the fragment D-induced increase in PA activity and the resultant increase in cell-associated plasmin may focally degrade underlying endothelial matrix and thus mediate the detachment of endothelial cells.
The role of plasmin generation by increased PA activity in mediating fragment D-induced endothelial cell detachment was examined using anti-uPA antibody, uPA inhibitor, or plasmin inhibitor. Pretreatment of endothelial cells with anti-uPA polyclonal antibody, uPA inhibitor (dansyl-GGACK), or plasmin inhibitor (aprotinin) prevented -60% of the fragment D-induced cell detachment, whereas nonimmune IgG (control antibody) showed no protection. These inhibitors were shown to prevent the proteolysis of the subendothelial-coated fibrinogen and vitronectin. These results support the hypothesis that endothelial cell detachment involves the release of PAs from BPAEC, generation of plasmin, and subsequent extracellular matrix proteolysis. This sequence linking upregulation of endothelial fibrinolytic activity to extracellular matrix degradation may mediate the observed fragment D-induced endothelial injury.
There was a significant delay in endothelial cell detachment in contrast to the relatively rapid increases in PA and plasmin activities. Although fragment D significantly increased BPAEC-bound plasmin activity, the concentration of the generated plasmin was -0.5 nM/liter. Therefore, at low concentrations of plasmin, there may be gradual and progressive disruption of cell-cell and cell-substratum adhesion sites, which may account for the delayed cell detachment. We cannot rule out the possibility that uPA/plasmin-independent mechanisms also contributed to fragment D-induced endothelial cell detachment, particularly since the results indicated that the inhibitors and antibodies partially prevented endothelial cell detachment. We have observed that fragment D endothelial-conditioned media in 12 to 24 h, which were not inhibited by aprotinin and dansyl-GGACK (unpublished observation). These enzymes may also contribute to the degradation ofcertain extracellular matrix proteins (e.g., collagen) and cell detachment.
We noted that there was a decline in PA activity after 8 h of fragment D challenge whereas the antigen concentrations of both tPA and uPA did not decrease when compared with the time-matched controls. This suggests increased inactivation of PAs, which may be due to the endothelial secretion of PAIs ( 10, 11, 12, 16, 24) . Whether fragment D induces endothelial expression and secretion of PAIs and whether they modulate fragment D-induced endothelial cell detachment is unknown. However, fragment D-induced PA secretion caused the relatively rapid generation ofplasmin, which was clearly the dominant factor responsible for degradation of extracellular matrix proteins and cell detachment as shown by the inhibitor studies.
In summary, we observed that purified fibrinogen fragment D increased the secretion of uPA and, to lesser extent, of tPA into the conditioned medium of BPAEC. Fragment D augmented the endothelial cell-associated plasmin activity and caused proteolysis of extracellular matrix proteins. Therefore, vascular endothelial injury after activation of fibrinolysis may be the result of fragment D-induced release of endothelial-derived PAs, focal generation of plasmin, and resultant degradation of subendothelial matrix. This pro-inflammatory role of FDP fragment D may be important in the pathogenesis of tissue inflammation associated with activation of fibrinolysis.
